Invenomic Capital Management LP Bausch & Lomb Corp Transaction History
Invenomic Capital Management LP
- $1.99 Billion
- Q2 2024
A detailed history of Invenomic Capital Management LP transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Invenomic Capital Management LP holds 762,451 shares of BLCO stock, worth $14.5 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
762,451
Previous 394,067
93.48%
Holding current value
$14.5 Million
Previous $6.82 Million
62.39%
% of portfolio
0.56%
Previous 0.37%
Shares
6 transactions
Others Institutions Holding BLCO
# of Institutions
95Shares Held
40.8MCall Options Held
66.8KPut Options Held
140K-
Fil LTD Hamilton, D06.66MShares$126 Million0.1% of portfolio
-
Goldentree Asset Management LP New York, NY5.1MShares$96.9 Million7.34% of portfolio
-
Maple Rock Capital Partners Inc. Toronto, A63.75MShares$71.1 Million1.84% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$66.5 Million0.47% of portfolio
-
River Road Asset Management, LLC1.93MShares$36.7 Million0.41% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $6.65B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...